BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 15825545)

  • 1. Multiple sclerosis in Newfoundland and Labrador--a model for disease prevalence.
    Sloka JS; Pryse-Phillips WE; Stefanelli M
    Can J Neurol Sci; 2005 Feb; 32(1):43-9. PubMed ID: 15825545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The unusual pattern of hereditary bleeding disorders in the province of Newfoundland and Labrador-Canada's most Eastern Province.
    Scully MF; Stoffman J; Boyd S
    Transfus Apher Sci; 2018 Dec; 57(6):713-716. PubMed ID: 30455155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and prevalence of multiple sclerosis in Newfoundland and Labrador.
    Sloka JS; Pryse-Phillips WE; Stefanelli M
    Can J Neurol Sci; 2005 Feb; 32(1):37-42. PubMed ID: 15825544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation of ultraviolet radiation and multiple sclerosis in Newfoundland.
    Sloka JS; Pryse-Phillips WE; Stefanelli M
    Can J Neurol Sci; 2008 Mar; 35(1):69-74. PubMed ID: 18380280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence and prevalence of multiple sclerosis in Newfoundland and Labrador, 1960-1984.
    Pryse-Phillips WE
    Ann Neurol; 1986 Sep; 20(3):323-8. PubMed ID: 3767317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latitudinal variation in the prevalence of multiple sclerosis in Ireland, an effect of genetic diversity.
    McGuigan C; McCarthy A; Quigley C; Bannan L; Hawkins SA; Hutchinson M
    J Neurol Neurosurg Psychiatry; 2004 Apr; 75(4):572-6. PubMed ID: 15026499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of severe burn among children in Newfoundland and Labrador, Canada.
    Alaghehbandan R; Sikdar KC; Gladney N; MacDonald D; Collins KD
    Burns; 2012 Feb; 38(1):136-40. PubMed ID: 22103990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Newfoundland and Labrador mosaic founder population descends from an Irish and British diaspora from 300 years ago.
    Gilbert E; Zurel H; MacMillan ME; Demiriz S; Mirhendi S; Merrigan M; O'Reilly S; Molloy AM; Brody LC; Bodmer W; Leach RA; Scott REM; Mugford G; Randhawa R; Stephens JC; Symington AL; Cavalleri GL; Phillips MS
    Commun Biol; 2023 Apr; 6(1):469. PubMed ID: 37117635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia.
    Hammond SR; English DR; McLeod JG
    Brain; 2000 May; 123 ( Pt 5)():968-74. PubMed ID: 10775541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A minimal prevalence study of diagnosed diabetes in Newfoundland and Labrador.
    Worrall G; Fodor G; Butt M
    Can J Public Health; 1991; 82(2):104-8. PubMed ID: 2049700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Latitudinal variation in MS incidence in Scotland.
    McDonald JJ; Weller B; O'Neil M; Waters C; O'Riordan J;
    Mult Scler Relat Disord; 2019 Jul; 32():116-122. PubMed ID: 31112929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latitudinal prevalence gradient of multiple sclerosis in Latin America.
    Risco J; Maldonado H; Luna L; Osada J; Ruiz P; Juarez A; Vizcarra D
    Mult Scler; 2011 Sep; 17(9):1055-9. PubMed ID: 21551216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Trichinella spiralis in black bears (Ursus americanus) from Newfoundland and Labrador, Canada.
    Butler CE; Khan RA
    J Wildl Dis; 1992 Jul; 28(3):474-5. PubMed ID: 1512886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Discontinuity between the Maritime Archaic and Beothuk Populations in Newfoundland, Canada.
    Duggan AT; Harris AJT; Marciniak S; Marshall I; Kuch M; Kitchen A; Renaud G; Southon J; Fuller B; Young J; Fiedel S; Golding GB; Grimes V; Poinar H
    Curr Biol; 2017 Oct; 27(20):3149-3156.e11. PubMed ID: 29033326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple sclerosis in the Iranian immigrant population of BC, Canada: prevalence and risk factors.
    Guimond C; Lee JD; Ramagopalan SV; Dyment DA; Hanwell H; Giovannoni G; Criscuoli M; Yee IM; Vorobeychik G; Ebers GC; Sadovnick AD
    Mult Scler; 2014 Aug; 20(9):1182-8. PubMed ID: 24414537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of specific cardiovascular disease risk factors in young Newfoundland and Labrador adults living in urban and rural communities.
    Kettle SM; Roebothan BV; West R
    Can J Rural Med; 2005; 10(2):81-5. PubMed ID: 15842789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relation between menarche and the age of first symptoms in a multiple sclerosis cohort.
    Sloka JS; Pryse-Phillips WE; Stefanelli M
    Mult Scler; 2006 Jun; 12(3):333-9. PubMed ID: 16764348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Where did the doctors go? A study of retention and migration of provisionally licensed international medical graduates practising in Newfoundland and Labrador between 1995 and 2006.
    Audas R; Ryan A; Vardy D
    Can J Rural Med; 2009; 14(1):21-4. PubMed ID: 19146788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple sclerosis in the Orkney and Shetland Islands. I: Epidemiology, clinical factors, and methodology.
    Poskanzer DC; Prenney LB; Sheridan JL; Kondy JY
    J Epidemiol Community Health; 1980 Dec; 34(4):229-39. PubMed ID: 7241022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of multiple sclerosis in Canada: a systematic review.
    Poppe AY; Wolfson C; Zhu B
    Can J Neurol Sci; 2008 Nov; 35(5):593-601. PubMed ID: 19235443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.